The Stochastic Oscillator for KRMD moved into oversold territory on November 03, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where KRMD's RSI Indicator exited the oversold zone, 15 of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on KRMD as a result. In 88 of 111 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for KRMD just turned positive on October 12, 2026. Looking at past instances where KRMD's MACD turned positive, the stock continued to rise in 39 of 48 cases over the following month. The odds of a continued upward trend are 81%.
Following a +3.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where KRMD advanced for three days, in 178 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 144 of 167 cases where KRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
KRMD moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
KRMD broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.929) is normal, around the industry mean (4.946). KRMD has a moderately low P/E Ratio (-77.500) as compared to the industry average of (38.797). Projected Growth (PEG Ratio) (1.770) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.292) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. KRMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 93 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KRMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PDEX advanced for three days, in 242 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PDEX's RSI Oscillator exited the oversold zone, 25 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on PDEX as a result. In 81 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
PDEX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Moving Average Convergence Divergence Histogram (MACD) for PDEX turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 42 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
PDEX moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PDEX crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PDEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Aroon Indicator for PDEX entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 54 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. PDEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.051) is normal, around the industry mean (4.946). P/E Ratio (14.208) is within average values for comparable stocks, (38.797). Projected Growth (PEG Ratio) (0.400) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.061) is also within normal values, averaging (56.876).
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
KRMD | PDEX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 43 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 57 Fair valued | |
PROFIT vs RISK RATING 1..100 | 93 | 54 | |
SMR RATING 1..100 | 94 | 31 | |
PRICE GROWTH RATING 1..100 | 63 | 56 | |
P/E GROWTH RATING 1..100 | 21 | 14 | |
SEASONALITY SCORE 1..100 | 90 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
KRMD's Valuation (9) in the null industry is somewhat better than the same rating for PDEX (57) in the Medical Or Nursing Services industry. This means that KRMD’s stock grew somewhat faster than PDEX’s over the last 12 months.
PDEX's Profit vs Risk Rating (54) in the Medical Or Nursing Services industry is somewhat better than the same rating for KRMD (93) in the null industry. This means that PDEX’s stock grew somewhat faster than KRMD’s over the last 12 months.
PDEX's SMR Rating (31) in the Medical Or Nursing Services industry is somewhat better than the same rating for KRMD (94) in the null industry. This means that PDEX’s stock grew somewhat faster than KRMD’s over the last 12 months.
PDEX's Price Growth Rating (56) in the Medical Or Nursing Services industry is in the same range as KRMD (63) in the null industry. This means that PDEX’s stock grew similarly to KRMD’s over the last 12 months.
PDEX's P/E Growth Rating (14) in the Medical Or Nursing Services industry is in the same range as KRMD (21) in the null industry. This means that PDEX’s stock grew similarly to KRMD’s over the last 12 months.
| KRMD | PDEX | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 83% | 1 day ago 81% |
| Stochastic ODDS (%) | 1 day ago 88% | 1 day ago 78% |
| Momentum ODDS (%) | 1 day ago 79% | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 81% | 1 day ago 89% |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 70% |
| Advances ODDS (%) | 1 day ago 78% | 8 days ago 85% |
| Declines ODDS (%) | 20 days ago 81% | 3 days ago 75% |
| BollingerBands ODDS (%) | 1 day ago 77% | 3 days ago 65% |
| Aroon ODDS (%) | 1 day ago 86% | 1 day ago 58% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KRMD’s FA Score shows that 2 FA rating(s) are green while PDEX’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KRMD’s TA Score shows that 6 TA indicator(s) are bullish while PDEX’s TA Score has 5 bullish TA indicator(s).
KRMD (@Pharmaceuticals: Other) experienced а -2.21% price change this week, while PDEX (@Pharmaceuticals: Other) price change was -3.26% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.70%. For the same industry, the average monthly price growth was -1.70%, and the average quarterly price growth was +10.08%.
KRMD is expected to report earnings on Nov 10, 2026.
PDEX is expected to report earnings on Feb 04, 2027.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor indicates that over the last year, KRMD has been loosely correlated with QDEL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KRMD jumps, then QDEL could also see price increases.
| Ticker / NAME | Correlation To KRMD | 1D Price Change % | ||
|---|---|---|---|---|
| KRMD | 100% | +1.64% | ||
| QDEL - KRMD | 40% Loosely correlated | +0.43% | ||
| A - KRMD | 40% Loosely correlated | +2.02% | ||
| CLPT - KRMD | 39% Loosely correlated | -2.41% | ||
| BIO - KRMD | 38% Loosely correlated | +2.39% | ||
| NVST - KRMD | 35% Loosely correlated | +0.24% | ||
More | ||||
A.I.dvisor tells us that PDEX and TCMD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDEX and TCMD's prices will move in lockstep.
| Ticker / NAME | Correlation To PDEX | 1D Price Change % | ||
|---|---|---|---|---|
| PDEX | 100% | +4.49% | ||
| TCMD - PDEX | 24% Poorly correlated | +8.35% | ||
| PRE - PDEX | 23% Poorly correlated | -1.70% | ||
| KRMD - PDEX | 23% Poorly correlated | +1.64% | ||
| WAT - PDEX | 23% Poorly correlated | +2.31% | ||
| GKOS - PDEX | 23% Poorly correlated | -2.33% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DDTO | 23.59 | 0.07 | +0.32% |
| Innovator Equity Dual Directional 10 Buffer ETF - October (DDTO) | |||
| TQQY | 11.38 | 0.02 | +0.14% |
| GraniteShares YieldBOOST QQQ ETF (TQQY) | |||
| CGIC | 34.83 | -0.09 | -0.26% |
| Capital Group International Core Equity ETF (CGIC) | |||
| WEA | 9.72 | -0.07 | -0.72% |
| Western Asset Premier | |||
| SETM | 23.99 | -0.39 | -1.60% |
| Sprott Critical Materials ETF (SETM) | |||